Instruction for use: Ferretab comp.

Dosage form: Sustained-release capsules

Active substance: Ferri fumaras+Acidum folicum

ATX

B03AD02 Iron fumarate in combination with folic acid

Pharmacological groups

Macro and microelements in combinations

Stimulants of hemopoiesis in combinations

The nosological classification (ICD-10)

D50 Iron deficiency anemia: Iron deficiency in food; Anemia due to violations of hemoglobin synthesis and iron metabolism; Anemia of iron deficiency; Iron / folic deficiency anemia; Iron deficiency anemia

E61.1 Insufficiency of iron: Insufficient food intake of iron; Iron deficiency; Iron deficiency in women during pregnancy; Deficiency of iron and folic acid in pregnancy; Iron deficiency after surgery; Latent iron deficiency; Lack of iron during pregnancy and lactation; Inadequate intake of iron from food; Increased need for iron; Increased need for iron during menstruation; Disturbances of iron absorption from the digestive tract; Severe iron deficiency

E63.1 Unbalanced intake of nutritional elements: An additional source of microelements Disturbances in nutrition; Malnutrition; Lack of fresh vegetables; Inadequate nutrition; Unbalanced and defective food, especially in the spring-winter period; Increased demand for mineral substances; Increased body requirement for vitamin C; Multivitamin deficiency; Weight Loss

K90.9 Disturbance of absorption in the intestine, unspecified: Insufficient absorption of iron from the gastrointestinal tract; Inadequate digestion of food; Disturbance of iron absorption in the digestive tract; Disturbance of absorption of vitamin B1 in the intestine

O25 Malnutrition in pregnancy: Hypovitaminosis during pregnancy; Deficiency of vitamins and minerals in pregnancy; Deficiency of iron and folic acid in pregnancy; Iron deficiency in women during pregnancy; Iodine deficiency in pregnancy; Iodine deficiency in lactating women; Calcium deficiency in the mother's body; Calcium deficiency in pregnant women; Mineral deficiency during pregnancy; An additional source of folic acid during pregnancy; Correction of calcium metabolism disorders during pregnancy; Lack of iron during pregnancy and lactation; Pregnancy Period; Breastfeeding period; Increased need for vitamin B1 in pregnancy

O99.0 Anemia complicating pregnancy, childbirth and the post-natal period: Anemia during pregnancy; Anemia in the mother; Iron deficiency anemia in pregnancy; Megaloblastic anemia of pregnant women; Iron deficiency anemia in pregnant women

R58 Bleeding, not elsewhere classified: Abdominal apoplexy; Hemorrhagia; Haemorrhage of the esophagus; Hemorrhage; Generalized bleeding; Diffuse bleeding; Diffuse bleeding; Prolonged bleeding; Blood loss; Blood loss during surgical interventions; Bleeding during surgery and in the postoperative period; Bleeding during labor; Bleeding and haemorrhage in hemophilia B; Bleeding from the gums; Bleeding intraoperative abdominal; Bleeding against a background of coumarin anticoagulants; Hepatic hepatitis; Bleeding in hemophilia A; Bleeding at hemophilia A; Bleeding with inhibitory forms of hemophilia A and B; Bleeding due to leukemia; Bleeding in patients with leukemia; Bleeding; Bleeding due to portal hypertension; Bleeding due to hyperfibrinolysis; Drug bleeding; Local bleeding; Local bleeding due to activation of fibrinolysis; Massive blood loss; Acute blood loss; Parenchymal hemorrhage; Hepatic bleeding; Postoperative hemorrhage; Kidney bleeding; Vascular-platelet hemostasis; Traumatic bleeding; Threatening bleeding; Chronic blood loss

Composition

Capsules of prolonged action - 1 caps.

1 capsule contains 3 mini tablets with iron fumarate and 1 mini tablet with folic acid

Active substances: Iron fumarate 163.56 mg

(In terms of dry matter 152.1 mg, equivalent to iron (II) 50 mg)

Folic acid 0.54 mg

(In terms of dry matter - 0.5 mg)

Excipients

Mini tablets iron fumarate: lactose monohydrate - 3.42 mg; Silicon dioxide colloidal - 0.6 mg; Magnesium stearate - 0.6 mg; Methyl methacrylate and ethyl acrylate copolymer (2: 1) - 4.66 mg

Mini-tablet of folic acid: lactose monohydrate - 24.21 mg; MCC - 24,25 mg; Silicon dioxide colloidal - 0.5 mg; Magnesium stearate - 0.5 mg

Capsule body: gelatin - 36.4804 mg; Dye azorubin - 0,0742 mg; Dye quinoline yellow - 0.1484 mg; Titanium dioxide - 0.496 mg

Cap capsule: gelatin - 24,3203 mg; Dye azorubin - 0.0498 mg; Dye quinoline yellow - 0.0996 mg; Titanium dioxide - 0.3303 mg

Pharmachologic effect

Mode of action - Replenishing iron deficiency, hematopoietic.

Dosing and Administration

Inside, 1 caps. A day on an empty stomach, plenty of liquids. With a severe lack of iron or folic acid, you need to increase the dose to 2 or 3 caps. per day. Supportive treatment should be continued at least 4 weeks after reaching the normal level of Hb for the normalization of serum ferritin, reflecting iron stores in the body.

Release form

Capsules of prolonged action. For 10 caps. In PVC / aluminum blister. By 3 bl. In a cardboard box.

Manufacturer

The holder of the registration certificate: LLC "VALEANT". 115162, Moscow, Shabolovka, 31, p. 5.

Manufacturer of ready-made dosage form, packer, packer: "G.L. Pharma GmbH ". Industrialstrasse, 1, A-8502 Lannach, Austria.

Issued quality control: "Lannacher Heilmittel GmbH." Schlossplatz, 1, A-8502 Lannach, Austria.

Claims of consumers to send to LLC "VALEANT": 115162, Moscow

Conditions of supply of pharmacies

On prescription.

Storage conditions of the drug Ferretab comp.

In dry, the dark place at a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life of the drug Ferretab comp.

3 years.

Do not use after the expiry date printed on the package.